These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7046716)

  • 21. Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroids.
    Wilson KM; Lord EM
    Br J Cancer; 1987 Feb; 55(2):141-6. PubMed ID: 3493024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro cytotoxicity of peritoneal macrophages activated with Mycobacterium smegmatis.
    Yamamoto S; Tokunaga T
    Microbiol Immunol; 1978; 22(1):27-40. PubMed ID: 661626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1985 Apr; 134(4):2658-65. PubMed ID: 3882833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of antitumor vaccine on the recurrence of solid tumors in mice subjected to surgery].
    Zatula DG; Bikhunov VL; Zagoruĭko EE
    Eksp Onkol; 1984; 6(1):47-9. PubMed ID: 6499731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
    Hopper KE; Harrison J; Nelson DS
    J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma.
    Symchych TV; Fedosova NI; Karaman ОМ; Yevstratieva LM; Potebnia HP
    Exp Oncol; 2017 Mar; 39(1):42-48. PubMed ID: 28361853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vivo lysis of tumor cells of varying degrees of immune resistance].
    Viksler VKh; Ustinov AS
    Eksp Onkol; 1989; 11(3):55-60. PubMed ID: 2752945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of Ehrlich ascites carcinoma in BCG-sensitized mice.
    Turcotte R
    Rev Can Biol; 1977 Sep; 36(3):253-63. PubMed ID: 928853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of antigens which stimulate T lymphocytes of Salmonella enteritidis 11RX immunized mice.
    Vordermeier HM; Kotlarski I
    Immunol Cell Biol; 1990 Oct; 68 ( Pt 5)():299-305. PubMed ID: 1707398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour cell toxicity for the targets of natural killer cells.
    Fuchs BB; Sterlina AG; Spirande IV; Zedginidze MS; Kogarko YN
    Folia Biol (Praha); 1983; 29(5):358-71. PubMed ID: 6642010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribonucleic acid in the immune response.
    Mitsuhashi S; Saito K; Kurashige S; Yamaguchi N
    Mol Cell Biochem; 1978 Aug; 20(3):131-47. PubMed ID: 81465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Salmonella enteritidis 11RX infection on two-stage skin carcinogenesis in mice.
    Ashman LK; Kotlarski I
    Aust J Exp Biol Med Sci; 1978 Dec; 56(6):695-701. PubMed ID: 110298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of antiserum fractions on Ehrlich ascites tumour cells.
    Wang M
    Br J Cancer; 1971 Jun; 25(2):315-22. PubMed ID: 5115831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the growth of Lewis lung carcinoma in syngeneic mice by Salmonella antigens.
    Ashman LK; Kotlarski I
    Aust J Exp Biol Med Sci; 1979 Dec; 57(6):637-9. PubMed ID: 398698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of Lyt-2+ cytotoxic T lymphocytes following primary and secondary Salmonella infection.
    Pope M; Kotlarski I; Doherty K
    Immunology; 1994 Feb; 81(2):177-82. PubMed ID: 7512524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR; Morris VA; Araujo FG; Remington JS
    J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A macrophage factor enhancing the systemic anti-tumour effect of T lymphocytes.
    van Loveren H; de Groot JW; Koten JW; Piersma AH; de Weger RA; den Otter W
    Immunobiology; 1984 Mar; 166(2):118-30. PubMed ID: 6609876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of interferon-gamma treatment of rat tumour cells on their susceptibility to natural killer cell, macrophage and cytotoxic T-cell killing.
    Yeoman H; Robins RA
    Immunology; 1988 Feb; 63(2):291-7. PubMed ID: 2965096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.